Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cipla
Cerilliant
Harvard Business School
Fish and Richardson
Chinese Patent Office
US Department of Justice
Moodys
Johnson and Johnson

Generated: July 15, 2018

DrugPatentWatch Database Preview

Diclofenac potassium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for diclofenac potassium and what is the scope of diclofenac potassium freedom to operate?

Diclofenac potassium
is the generic ingredient in four branded drugs marketed by Bionpharma Inc, Depomed Inc, Par Form, Novartis, Apotex, Casi Pharms Inc, Mylan, Sandoz, Sun Pharm Industries, Teva, and Watson Labs Teva, and is included in twelve NDAs. There are twelve patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Diclofenac potassium has fifty-four patent family members in twenty-nine countries.

There are forty-seven drug master file entries for diclofenac potassium. Twenty suppliers are listed for this compound.
Pharmacology for diclofenac potassium
Synonyms for diclofenac potassium
15307-81-0
15307-86-5 (Parent)
2-((2,6-dichlorophenyl)amino)benzeneacetic acid, monopotassium salt
AB0013318
AC-18735
AK163133
AKOS015889752
AKOS015994733
AN-8291
Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-, monopotassium salt
C14H10Cl2KNO2
C14H10Cl2NO2.K
Cambia
Cambia (TN)
Cataflam
Cataflam (TN)
CGP 45840B
CGP-45840B
CHEBI:4508
CHEMBL1200804
D00903
Diclofenac potassium (USAN)
Diclofenac potassium [USAN:USP]
Diclofenac potassium [USAN]
Diclofenic potassium
DR001603
DTXSID30165212
FT-0603076
H866
HMS3656D18
I01-3215
KS-5037
KXZOIWWTXOCYKR-UHFFFAOYSA-M
L4D5UA6CB4
LS-173441
MolPort-005-937-655
Potassium (o-(2,6-dichloroanilino)phenyl)acetate
potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
potassium 2-[2-(2,6-dichloroanilino)phenyl]acetate
potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
PubChem5895
s3062
SC-01315
SCHEMBL40784
ST51051764
UNII-L4D5UA6CB4
Voltfast
Zipsor
Zipsor (TN)

US Patents and Regulatory Information for diclofenac potassium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novartis CATAFLAM diclofenac potassium TABLET;ORAL 020142-001 Nov 24, 1993 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz DICLOFENAC POTASSIUM diclofenac potassium TABLET;ORAL 075582-001 Feb 23, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Depomed Inc ZIPSOR diclofenac potassium CAPSULE;ORAL 022202-001 Jun 16, 2009 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for diclofenac potassium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 ➤ Sign Up ➤ Sign Up
Depomed Inc CAMBIA diclofenac potassium FOR SOLUTION;ORAL 022165-001 Jun 17, 2009 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Teva
Express Scripts
Cipla
Farmers Insurance
Healthtrust
Cerilliant
UBS
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.